Inflammation Research

, Volume 67, Issue 5, pp 423–433 | Cite as

HIF-1A gene polymorphisms and its protein level in patients with rheumatoid arthritis: a case–control study

  • Agnieszka Paradowska-Gorycka
  • Barbara Stypinska
  • Andrzej Pawlik
  • Ewa Haladyj
  • Katarzyna Romanowska-Próchnicka
  • Marzena Olesinska
Original Research Paper
  • 65 Downloads

Abstract

Objectives

The aim of the study was to identify HIF-1A genetic variants and their possible association with HIF-1α, VEGF, KDR, RORc and Foxp3 protein levels, and susceptibility to and severity of RA.

Methods

The HIF-1A gene polymorphisms were genotyped for 587 RA patients and 341 healthy individuals. The HIF-1α, VEGF, KDR, RORc and Foxp3serum levels were evaluated.

Results

Under the codominant model, the frequency of the rs12434438 GG genotype was lower in RA patients than in controls (P = 0.02). Under the recessive model (AA + AG vs GG), the association was also significant (OR 3.32; CI 1.19–9.24; P = 0.02). Overall, rs12434438 A/G and rs1951795 A/C are in almost completed linkage disequilibrium with D′ = 0.96 and r2 = 0.85. The HIF-1A rs1951795 A allele was associated with rheumatoid factor (P = 0.02) and mean value of erythrocyte sedimentation rate (ESR) (P = 0.05). In RA patients with HIF-1A rs12434439 GG genotype, the parameters of disease activity such as DAS-28, VAS score, Larsen score or HAQ score were lower compared to RA patients with the HIF-1A rs12434439 AA genotype. Moreover, we also observed that Foxp3 serum levels were higher, and RORc2 serum levels were lower in RA patients with rs12434439 GG.

Conclusion

The polymorphic HIF-1A rs12434439 GG genotype may play a protective role for RA development.

Keywords

Gene polymorphisms Rheumatoid arthritis HIF-1α Angiogenesis Inflammation 

Notes

Acknowledgements

The technical assistance of Wieslawa Frankowska and Teresa Golaszewska is gratefully acknowledged. We are also grateful to all the RA patients and healthy subjects whose cooperation made this study possible.

Author contributions

APG conceived, designed and performed experiments, analyzed and interpreted data and wrote the first draft of the manuscript. BS performed experiments and statistical analysis. AP contributed to drafting the manuscript. KRP, EH and MO were involved in the classification of patients with rheumatoid arthritis, clinical check of patients and treatment control. All authors read and approved the final version.

Compliance with ethical standards

Conflict of interest

The authors declare that they have no conflict of interest.

Supplementary material

11_2018_1134_MOESM1_ESM.doc (192 kb)
Supplementary material 1 (DOC 192 KB)

References

  1. 1.
    Wang CH, Yao H, Chen LN, Jia JF, Wang L, Dai JY, et al. CD147 induces angiogenesis through a vascular endothelial growth factor and hypoxia-inducible transcription factor 1α-mediated pathway in rheumatoid arthritis. Arthritis Rheum. 2012;64:1818–27.CrossRefPubMedGoogle Scholar
  2. 2.
    Konisti S, Kiriakidis S, Paleolog EM. Hypoxia—a key regulator of angiogenesis and inflammation in rheumatoid arthritis. Nat Rev Rheumatol. 2012;8:153–62.CrossRefPubMedGoogle Scholar
  3. 3.
    Quiñonez-Flores CM, González-Chávez SA, Pacheco-Tena C. Hypoxia and its implications in rheumatoid arthritis. J Biomed Sci. 2016;23:62.CrossRefPubMedPubMedCentralGoogle Scholar
  4. 4.
    Deng W, Feng X, Li X, Wang D, Sun L. Hypoxia-inducible factor 1 in autoimmune diseases. Cell Immunol. 2016;303:7–15.CrossRefPubMedGoogle Scholar
  5. 5.
    Hu F, Liu H, Xu L, Li Y, Liu X, Shi L, et al. Hypoxia-inducible factor-1α perpetuates synovial fibroblast interactions with T cells and B cells in rheumatoid arthritis. Eur J Immunol. 2016;46:742–51.CrossRefPubMedGoogle Scholar
  6. 6.
    Jeon CH, Ahn JK, Chai JY, Kim HJ, Bae EK, Park SH, et al. Hypoxia appears at pre-arthritic stage and shows co-localization with early synovial inflammation in collagen induced arthritis. Clin Exp Rheumatol. 2008;26:646–8.PubMedGoogle Scholar
  7. 7.
    Maruotti N, Cantatore FP, Crivellato E, Vacca A, Ribatti D. Angiogeneis in rheumatoid arthritis. Histol Histopathol. 2006;21:557–66.PubMedGoogle Scholar
  8. 8.
    Koch AE, Harlow LA, Haines GK, Amento EP, Unemori EN, Wong WL, et al. Vascular endothelial growth factor. A cytokine modulating endothelial function in rheumatoid arthritis. J Immunol. 1994;152:4149–56.PubMedGoogle Scholar
  9. 9.
    Ballara S, Taylor PC, Reusch P, Marmé D, Feldmann M, Maini RN, et al. Raised serum vascular endothelial growth factor levels are associated with destructive change in inflammatory arthritis. Arthritis Rheum. 2001;44:2055–64.CrossRefPubMedGoogle Scholar
  10. 10.
    Kurosaka D, Hirai K, Nishioka M, Miyamoto Y, Yoshida K, Noda K, et al. Clinical significance of serum levels of vascular endothelial growth factor, angiopoietin-1, and angiopoietin-2 in patients with rheumatoid arthritis. J Rheumatol. 2010;37:1121–8.CrossRefPubMedGoogle Scholar
  11. 11.
    Paradowska-Gorycka A, Pawlik A, Romanowska-Prochnicka K, Haladyj E, Malinowski D, Stypinska B, et al. Relationship between VEGF gene polymorphisms and serum VEGF protein levels in patients with rheumatoid arthritis. PLoS One. 2016;11:e0160769.CrossRefPubMedPubMedCentralGoogle Scholar
  12. 12.
    Dang EV, Barbi J, Yang HY, Jinasena D, Yu H, Zheng Y, et al. Control of T(H)17/T(reg) balance by hypoxia-inducible factor 1. Cell. 2011;146:772–84.CrossRefPubMedPubMedCentralGoogle Scholar
  13. 13.
    Larsen H, Muz B, Khong TL, Feldmann M, Paleolog EM. Differential effects of Th1 versus Th2 cytokines in combination with hypoxia on HIFs and angiogenesis in RA. Arthritis Res Ther. 2012;14:R180.CrossRefPubMedPubMedCentralGoogle Scholar
  14. 14.
    Hot A, Zrioual S, Lenief V, Miossec P. IL-17 and tumour necrosis factor α combination induces a HIF-1α-dependent invasive phenotype in synoviocytes. Ann Rheum Dis. 2012;71:1393–401.CrossRefPubMedGoogle Scholar
  15. 15.
    Shen J, Li Z, Chen J, Song Z, Zhou Z, Shi Y. SHEsisPlus, a toolset for genetic studies on polyploid species. Sci Rep. 2016;6:24095.CrossRefPubMedPubMedCentralGoogle Scholar
  16. 16.
    Shi Y, He L. SHEsis, a powerful software platform for analyses of linkage disequilibrium, haplotype construction, and genetic association at polymorphism loci. Cell Res. 2005;15:97–8.CrossRefPubMedGoogle Scholar
  17. 17.
    Li Z, Zhang Z, He Z, Tang W, Li T, Zeng Z, et al. A partition-ligation-combination-subdivision EM algorithm for haplotype inference with multiallelic markers. Cell Res. 2009;19:519–23.CrossRefPubMedGoogle Scholar
  18. 18.
    Wipff J, Dieude P, Avouac J, Tiev K, Hachulla E, Granel B, et al. Association of hypoxia-inducible factor 1A (HIF1A) gene polymorphisms with systemic sclerosis in a French European Caucasian population. Scand J Rheumatol. 2009;38:291–4.CrossRefPubMedGoogle Scholar
  19. 19.
    Li P, Cao Q, Shao PF, Cai HZ, Zhou H, Chen JW. at al. Genetic polymorphisms in HIF1A are associated with prostate cancer risk in a Chinese population. Asian J Androl. 2012;14:864–9.CrossRefPubMedPubMedCentralGoogle Scholar
  20. 20.
    López-Reyes A, Rodríguez-Pérez JM, Fernández-Torres J, Martínez-Rodríguez N, Pérez-Hernández N, Fuentes-Gómez AJ, et al. The HIF1A rs2057482 polymorphism is associated with risk of developing premature coronary artery disease and with some metabolic and cardiovascular risk factors. The genetics of atherosclerotic disease (GEA) Mexican study. Exp Mol Pathol. 2014;96:405–10.CrossRefPubMedGoogle Scholar
  21. 21.
    Fernández-Torres J, Hernández-Díaz C, Espinosa-Morales R, Camacho-Galindo J, Galindo-Sevilla Ndel C, López-Macay Á, et al. Polymorphic variation of hypoxia inducible factor-1 A (HIF1A) gene might contribute to the development of knee osteoarthritis: a pilot study. BMC Musculoskelet Disord. 2015;16:218.CrossRefPubMedPubMedCentralGoogle Scholar
  22. 22.
    Wang X, Ren H, Zhao T, Ma W, Dong J, Zhang S, et al. Single nucleotide polymorphism in the microRNA-199a binding site of HIF1A gene is associated with pancreatic ductal adenocarcinoma risk and worse clinical outcomes. Oncotarget. 2016;7:13717–29.PubMedPubMedCentralGoogle Scholar
  23. 23.
    Yu ZG, Wang BZ, Cheng ZZ. The association of genetic polymorphisms of hypoxia inducible factor-1alpha and vascular endothelial growth factor with increased risk of chronic obstructive pulmonary disease: a case-control study Kaohsiung. J Med Sci. 2017;33:433–441.Google Scholar
  24. 24.
    Wei WT, Li B, Chen M, Jia HR, Zhang HX. Associations between HIF-1α polymorphisms C1772T and G1790A and susceptibility to chronic obstructive pulmonary disease. Genet Mol Res. 2015;14:17341–7.CrossRefPubMedGoogle Scholar
  25. 25.
    Bi YX, Yu L, Jin GX. Correlation between polymorphisms of hypoxia-inducible factor-1α Pro582Ser and type 2 diabetic nephropathy. Genet Mol Res. 2015;14:14503–9.CrossRefPubMedGoogle Scholar
  26. 26.
    Liao SH, Liu WZ, Liu T, Sun Y, Feng X. Zhou HF.Potential signaling pathway of hypoxia-inducible factor in lung cancer and its gene polymorphism with lung cancer risk. J Recept Signal Transduct Res. 2015;35(4):233–7.CrossRefPubMedGoogle Scholar
  27. 27.
    Guo X, Li D, Chen Y, An J, Wang K, Xu Z, et al. SNP rs2057482 in HIF1A gene predicts clinical outcome of aggressive hepatocellular carcinoma patients after surgery. Sci Rep. 2015;5:11846.CrossRefPubMedPubMedCentralGoogle Scholar
  28. 28.
    Hu F, Shi L, Mu R, Zhu J, Li Y, Ma X, et al. Hypoxia-inducible factor-1α and interleukin 33 form a regulatory circuit to perpetuate the inflammation in rheumatoid arthritis. PLoS One. 2013;8:e72650.CrossRefPubMedPubMedCentralGoogle Scholar
  29. 29.
    Wu J, Cui H, Zhu Z, Wang L, Li H, Wang D. Effect of HIF1α on Foxp3 expression in CD4+ CD25− T lymphocytes. Microbiol Immunol. 2014;58:409–415.CrossRefPubMedGoogle Scholar
  30. 30.
    Clambey ET, McNamee EN, Westrich JA, Glover LE, Campbell EL, Jedlicka P, et al. Hypoxia-inducible factor-1 alpha-dependent induction of FoxP3 drives regulatory T-cell abundance and function during inflammatory hypoxia of the mucosa. Proc Natl Acad Sci USA. 2012;109:E2784–2793.CrossRefPubMedPubMedCentralGoogle Scholar
  31. 31.
    hi LZ, Wang R, Huang G, Vogel P, Neale G, Green DR, et al. HIF1alpha-dependent glycolytic pathway orchestrates a metabolic checkpoint for the differentiation of TH17 and Treg cells. J Exp Med. 2011;208:1367–1376.CrossRefGoogle Scholar
  32. 32.
    Kao JK, Hsue YT, Lin CY. Role of new population of peripheral CD11c(+) CD8(+) T cells and CD4(+) CD25(+) regulatory T cells during acute and remission stages in rheumatoid arthritis patients. J Microbiol Immunol Infect. 2007;40:419–27.PubMedGoogle Scholar

Copyright information

© Springer International Publishing AG, part of Springer Nature 2018

Authors and Affiliations

  1. 1.Department of Biochemistry and Molecular BiologyNational Institute of Geriatrics, Rheumatology and RehabilitationWarsawPoland
  2. 2.Department of PhysiologyPomeranian Medical UniversitySzczecinPoland
  3. 3.Department of General and Experimental PathologyWarsaw Medical UniversityWarsawPoland
  4. 4.Department of Connective Tissue DiseasesNational Institute of Geriatrics, Rheumatology and RehabilitationWarsawPoland

Personalised recommendations